These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 36381906)
1. A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis. Rao SJ; Kumar K; Saleh N Cureus; 2022 Oct; 14(10):e30106. PubMed ID: 36381906 [TBL] [Abstract][Full Text] [Related]
2. Sodium-Glucose Co-transporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Bariatric Surgery: A Case and Literature Review. Kapila V; Topf J Cureus; 2021 Aug; 13(8):e17093. PubMed ID: 34527480 [TBL] [Abstract][Full Text] [Related]
3. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports. Juneja D; Nasa P; Jain R; Singh O World J Diabetes; 2023 Aug; 14(8):1314-1322. PubMed ID: 37664476 [TBL] [Abstract][Full Text] [Related]
4. Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers. Somagutta MR; Agadi K; Hange N; Jain MS; Batti E; Emuze BO; Amos-Arowoshegbe EO; Popescu S; Hanan S; Kumar VR; Pormento K Cureus; 2021 Mar; 13(3):e13665. PubMed ID: 33824816 [TBL] [Abstract][Full Text] [Related]
5. An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists. Kang CY; Khamooshi P; Reyes Pinzon V Cureus; 2022 Apr; 14(4):e24016. PubMed ID: 35573514 [TBL] [Abstract][Full Text] [Related]
6. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors - Lessons From a Case Series and Strategies to Decrease Incidence. Mehta PB; Robinson A; Burkhardt D; Rushakoff RJ Endocr Pract; 2022 Sep; 28(9):884-888. PubMed ID: 35753675 [TBL] [Abstract][Full Text] [Related]
7. Severe Prolonged SGLT2i-induced Euglycemic Diabetic Ketoacidosis Refractory to Standard Therapy and Dialysis: Case Report and Literature Review. Almazrouei R; Alkindi F; Alshamsi A; Dawoud T; Chaaban A; Rahman MU Oman Med J; 2022 May; 37(3):e373. PubMed ID: 35712376 [TBL] [Abstract][Full Text] [Related]
8. A Case of Prolonged Recovery for Post-percutaneous Coronary Intervention (PCI) Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis in a 28-Year-Old. Petersen C; Gyabaah F; Sotelo J; Yohanna S; Deoker A Cureus; 2023 Sep; 15(9):e45180. PubMed ID: 37842482 [TBL] [Abstract][Full Text] [Related]
9. Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report. VonTungeln CD; Al Bataineh M Cureus; 2024 Jan; 16(1):e52122. PubMed ID: 38344581 [TBL] [Abstract][Full Text] [Related]
10. A Literature Review of the Therapeutic Perspectives of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor-Induced Euglycemic Diabetic Ketoacidosis. Patel K; Nair A Cureus; 2022 Sep; 14(9):e29652. PubMed ID: 36320965 [TBL] [Abstract][Full Text] [Related]
11. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature. Diaz-Ramos A; Eilbert W; Marquez D Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052 [TBL] [Abstract][Full Text] [Related]
12. Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports. Altowayan WM Ann Med Surg (Lond); 2022 Dec; 84():104879. PubMed ID: 36582864 [TBL] [Abstract][Full Text] [Related]
14. Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis. Yu X; Zhang S; Zhang L Int J Endocrinol; 2018; 2018():7074868. PubMed ID: 30369948 [TBL] [Abstract][Full Text] [Related]
15. Sodium-Glucose Cotransporter-2 Inhibitor-associated Euglycemic Diabetic Ketoacidosis: Lessons From a Case Series of 4 Patients Undergoing Coronary Artery Bypass Grafting Surgery. Chaudhry A; Roels C; Lee J Can J Diabetes; 2022 Dec; 46(8):843-850. PubMed ID: 36068154 [TBL] [Abstract][Full Text] [Related]
16. Dietary Changes Leading to Euglycemic Diabetic Ketoacidosis in Sodium-Glucose Cotransporter-2 Inhibitor Users: A Challenge for Primary Care Physicians? Somagutta MKR; Uday U; Shama N; Bathula NR; Pendyala S; Mahadevaiah A; Mahmutaj G; Ngardig NN Korean J Fam Med; 2022 Nov; 43(6):361-366. PubMed ID: 36444120 [TBL] [Abstract][Full Text] [Related]
17. Euglycemic diabetic ketoacidosis associated with ST segment elevation myocardial infarction following SGLT-2 inhibitor therapy. Baytuğan NZ; Çelik Aİ; Bezgin T; Çağdaş M Am J Emerg Med; 2023 Sep; 71():250.e1-250.e3. PubMed ID: 37451968 [TBL] [Abstract][Full Text] [Related]
18. Case Report: High-Calorie Glucose Infusion and Tight Glycemic Control in Ameliorating Refractory Acidosis of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis. Wan Azman SS; Sukor N; Abu Shamsi MY; Ismail I; Kamaruddin NA Front Endocrinol (Lausanne); 2022; 13():867647. PubMed ID: 35712244 [TBL] [Abstract][Full Text] [Related]